Access the full text.
Sign up today, get DeepDyve free for 14 days.
S. Morison, J. Dodge, T. Cole, P. Lewis, E. Coles, D. Geddes, G. Russell, J. Littlewood, M. Scott (1997)
Height and weight in cystic fibrosis: a cross sectional studyArchives of Disease in Childhood, 77
Continuous and intermittent antibiotic therapy in cystic fibrosis patients to age 4 years
H. Shwachman, L. Kulczycki (1958)
Long-term study of one hundred five patients with cystic fibrosis; studies made over a five- to fourteen-year period.A.M.A. journal of diseases of children, 96 1
R. Knudson, M. Lebowitz, C. Holberg, B. Burrows (1983)
Changes in the normal maximal expiratory flow-volume curve with growth and aging.The American review of respiratory disease, 127 6
A. Smyth, S. Walters (2014)
Prophylactic anti-staphylococcal antibiotics for cystic fibrosis.The Cochrane database of systematic reviews, 11
S. Chatfield, G. Owen, H. Ryley, Joanne Williams, M. Alfaham, M. Goodchild, P. Weller (1991)
Neonatal screening for cystic fibrosis in Wales and the West Midlands: clinical assessment after five years of screening.Archives of Disease in Childhood, 66
R. Shapera, Warren Warwick, John Matsen (1981)
Clindamycin therapy of staphylococcal pulmonary infections in patients with cystic fibrosis.The Journal of pediatrics, 99 4
D. Armstrong, K. Grimwood, R. Carzino, J. Carlin, A. Olinsky, P. Phelan (1995)
Lower respiratory infection and inflammation in infants with newly diagnosed cystic fibrosisBMJ, 310
Gordon Wright, James Harper (1970)
Fusidic acid and lincomycin therapy in staphylococcal infections in cystic fibrosis.Lancet, 1 7636
(2015)
Children with cystic fibrosis: understanding issues related to oral administration of liquid flucloxacillin
N. Pillarisetti, E. Williamson, B. Linnane, B. Skoric, C. Robertson, P. Robinson, J. Massie, G. Hall, P. Sly, S. Stick, S. Ranganathan (2011)
Infection, inflammation, and lung function decline in infants with cystic fibrosis.American journal of respiratory and critical care medicine, 184 1
D. Armstrong, K. Grimwood, J. Carlin, R. Carzino, A. Olinsky, Peter Phenlan (1996)
Bronchoalveolar lavage or oropharyngeal cultures to identify lower respiratory pathogens in infants with cystic fibrosisPediatric Pulmonology, 21
Manuscript title: A mixed methods study of the administration of flucloxacillin oral liquid; identifying strategies to overcome administration issues of medicines with poor palatability
D. Moher, K. Schulz, D. Altman (2001)
The CONSORT statement: revised recommendations for improving the quality of reports of parallel-group randomised trialsThe Lancet, 357
(1992)
Cephalexin prophylaxis in newly diagnosed infants with cystic fibrosis
C Beardsmore, John Thompson, Anne Williams, K. McArdle, G Gregory, L Weaver, Hamish Simpson, E. McArdle (1994)
Pulmonary function in infants with cystic fibrosis: the effect of antibiotic treatment.Archives of Disease in Childhood, 71
R. Keel, André Schaeftlein, C. Kloft, J. Pope, R. Knauft, M. Muhlebach, D. Nicolau, J. Kuti (2011)
Pharmacokinetics of Intravenous and Oral Linezolid in Adults with Cystic FibrosisAntimicrobial Agents and Chemotherapy, 55
L Weaver, M Green, K. Nicholson, J. Mills, M. Heeley, J. Kuzemko, S. Austin, G Gregory, A Dux, J Davis (1994)
Prognosis in cystic fibrosis treated with continuous flucloxacillin from the neonatal period.Archives of Disease in Childhood, 70
Schlesinger 1984 {unpublished data only}
G. Nolan, P. McIvor, Henry Levison, P. Fleming, M. Corey, Ronald Gold (1982)
Antibiotic prophylaxis in cystic fibrosis: inhaled cephaloridine as an adjunct to oral cloxacillin.The Journal of pediatrics, 101 4
M. Szaff, N. HØiby (1982)
ANTIBIOTIC TREATMENT OF STAPHYLOCOCCUS AUREUS INFECTION IN CYSTIC FIBROSISActa Pædiatrica, 71
Longitudinal relationship between clinical status, lung infection and immune responses in young cystic fibrosis patients
A. Chrispin, A. Norman (2005)
The systematic evaluation of the chest radiograph in cystic fibrosisPediatric Radiology, 2
H. Stutman, J. Lieberman, E. Nussbaum, M. Marks (2002)
Antibiotic prophylaxis in infants and young children with cystic fibrosis: a randomized controlled trial.The Journal of pediatrics, 140 3
A. Smyth, S. Walters (2003)
Prophylactic antibiotics for cystic fibrosis.The Cochrane database of systematic reviews, 3
T. Jensen, S. Lanng, Mette Faber, V. Rosdahl, N. Høiby, Christian Koch (1990)
Clinical experiences with fusidic acid in cystic fibrosis patients.The Journal of antimicrobial chemotherapy, 25 Suppl B
John Brown (1980)
Efficacy of antimicrobial drugs against staphylococci in cystic fibrosisJournal of Paediatrics and Child Health, 16
A. Norman (1967)
FUCIDIC ACID IN CYSTIC FIBROSISThe Lancet, 290
V. Loening-Baucke, E. Mischler, M. Myers (1979)
A placebo-controlled trial of cephalexin therapy in the ambulatory management of patients with cystic fibrosis.The Journal of pediatrics, 95 4
(1985)
A multicentric comparison of related pharmacologic features of cephalexin and dicloxacillin given for two months to young children with cystic fibrosis
V. Loening-Baucke, E. Mischler, M. Myers (1978)
790 CEPHALEXIN IN CYSTIC FIBROSIS: A PLACEBO-CONTROLLED STUDYPediatric Research, 12
E Walters, J Walters (1999)
Many reports of RCTs give insufficient data for Cochrane reviewersBMJ, 319
E. Kerem, J. Reisman, M. Corey, G. Canny, H. Levison (1992)
Prediction of mortality in patients with cystic fibrosis.The New England journal of medicine, 326 18
J. Higgins, D. Altman (2008)
Chapter 8: Assessing risk of bias in included studies
K. McCaffery, R. Olver, M. Franklin, S. Mukhopadhyay (1999)
Systematic review of antistaphylococcal antibiotic therapy in cystic fibrosisThorax, 54
M. Keller, A. Coates, M. Griese, O. Denk, J. Schierholz, M. Knoch (2010)
In-vivo data support equivalent therapeutic efficacy of a new tobramycin inhalation solution (150 mg/1.5 ml) administered by the eFlow® electronic nebuliser compared to TOBI® in the PARI LC PLUS®Journal of Cystic Fibrosis, 9
D. Moher, K. Schulz, D. Altman, F. Group (2003)
The CONSORT statement: revised recommendations for improving the quality of reports of parallel-group randomised trialsClinical Oral Investigations, 7
S. Ballestero, R. Villaverde, H. Escobar, F. Baquero (1992)
Susceptibility to various antimicrobial agents ofStaphylococcus aureus isolates from cystic fibrosis patientsEuropean Journal of Clinical Microbiology and Infectious Diseases, 11
(1991)
Continuous prophylactic flucloxacillin improves outcome of infants with cystic fibrosis (CF) detected soon a er birth
E ect of long-term continuous anti-staphylococcal antibiotic treatment in young children with cystic fibrosis [abstract
Cochrane Database of Systematic Reviews – Unpaywall
Published: Sep 30, 2020
Read and print from thousands of top scholarly journals.
Already have an account? Log in
Bookmark this article. You can see your Bookmarks on your DeepDyve Library.
To save an article, log in first, or sign up for a DeepDyve account if you don’t already have one.
Copy and paste the desired citation format or use the link below to download a file formatted for EndNote
Access the full text.
Sign up today, get DeepDyve free for 14 days.
All DeepDyve websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.